Patent · US Active

Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof

US12152015B2 · kind B2 · utility

0Cited by
1References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 14, 2023
Grant dateNov 26, 2024
Priority date
Expiry dateFeb 14, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds and methods for their preparation and use as therapeutic or prophylactic agents, for example for treatment of cancer, bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.